Abstract
There is considerable debate regarding the negative impact of concomitant proton pump inhibitor (PPI) therapy on the antiplatelet efficacy of clopidogrel.
Original language | English |
---|---|
Pages (from-to) | 127-39 |
Number of pages | 13 |
Journal | Drug Safety |
Volume | 35 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2012 |
Keywords
- Blood Platelets
- Drug Interactions
- Esomeprazole Sodium
- Humans
- Omeprazole
- Platelet Aggregation
- Platelet Aggregation Inhibitors
- Proton Pump Inhibitors
- Randomized Controlled Trials as Topic
- Ticlopidine